BioSpace News Archive

Tilray Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY), a global pioneer in cannabis production, research, cultivation and distribution, announced today it will report results for the third quarter ended September 30, 2020 on Monday, November 9, 2020 after market close.

CONMED Corporation (NYSE: CNMD) today announced financial results for the third quarter ended September 30, 2020. Third Quarter 2020 Highlights Sales of $237.8 million increased 1.8% year over year as reported and in constant currency. Domestic revenue increased 4.7% year over year. International revenue decreased 1.7% as reported and in constant currency. Diluted net earnings per share

Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, today announced that Histogen’s financial results for the third quarter ended September 30, 2020 will be released after the close of market on Thursday, November 12, 2020. About Histogen Inc. Histogen Inc. is a clin

Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX: VMD.TO and NASDAQ:VMD), a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced its support for the Centers for Medicare & Medicaid Services’ (“CMS”) recent decision to remove oxygen and positive airway pressure (“PAP”) devices from the Competitive Bidding Program (“CBP”) beginning January 1, 2021

Normally, the presence of Group B Streptococcus (GBS) is nothing to worry about, but for pregnant women this Gram-positive bacterium can be deadly — if transferred to infants during labor.

Theator’s collaboration with SAGES marks the first time a surgical society is harnessing AI-based video technology for surgeon evaluation

MMS Holdings – an award-winning, data-focused CRO – announced that its learning arm, MMS Academy, now offers access to all of its virtual pharmaceutical industry courses through a mobile smart device application.

New TTS Stent Allows Physicians to Provide Precise Treatment Under Direct Scope Visualization

Building off of a successful 25 year partnership that has raised $86 million to tackle the nation’s maternal and infant health crisis, March of Dimes and Publix Super Markets, Inc. are pleased to announce their latest fundraising campaign to ensure every mom and baby have the best possible start.

Therapies Based on Extensive Neuropathic Pain Research Conducted at UC Riverside and Duke University Target Chronic Pain at Its Source: Matrix Metalloproteinases